Kamada (KMDA) Gains from Equity Investments (2012 - 2026)
Kamada (KMDA) posted Gains from Equity Investments of $9.26 million for the quarter ended Jun 30, 2026, up 25.6% from $7.38 million a year earlier and up 124.2% from the prior quarter.
Kamada (KMDA) Gains from Equity Investments (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gains from Equity Investments at Kamada was $22.25 million, up 17.0% year-over-year; for the year ended Dec 31, 2025, it came in at $20.2 million, up 39.7% from the prior year.
- Annual Gains from Equity Investments shows a five-year compound annual growth rate of 3.3% (years ended Dec 2020 to Dec 2025).
- In prior years, Kamada's Gains from Equity Investments was $14.46 million in the year ended Dec 31, 2024 (+74.6%), $8.28 million in the year ended Dec 31, 2023 and -$2.23 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly Gains from Equity Investments since the quarter ended Dec 31, 2018.
- On a year-over-year basis, Gains from Equity Investments increased in five of the last seven quarters, with growth averaging 17.5%.
- The strongest year-over-year quarter for Gains from Equity Investments in the past five years was the quarter ended Jun 30, 2024, with growth of 144.3%; the weakest was the quarter ended Dec 31, 2024, with a decline of 24.7%.
- According to Business Quant data, Gains from Equity Investments for the three prior quarters was $4.13 million (quarter ended Mar 31, 2026), $3.56 million (quarter ended Dec 31, 2025) and $5.3 million (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Kamada | 479.37 Mn | 188.43 Mn | 22.47 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.26 Mn |
| Mar 31, 2026 | 4.13 Mn |
| Dec 31, 2025 | 3.56 Mn |
| Sep 30, 2025 | 5.30 Mn |
| Jun 30, 2025 | 7.38 Mn |
| Mar 31, 2025 | 3.96 Mn |
| Dec 31, 2024 | 3.81 Mn |
| Sep 30, 2024 | 3.86 Mn |
| Jun 30, 2024 | 4.43 Mn |
| Dec 31, 2023 | 5.06 Mn |
| Sep 30, 2023 | 3.22 Mn |
| Jun 30, 2023 | 1.81 Mn |
| Mar 31, 2022 | -1.83 Mn |
| Dec 31, 2021 | -5.01 Mn |
| Sep 30, 2021 | -845,000.00 |
| Jun 30, 2021 | 937,000.00 |
| Mar 31, 2021 | 2.69 Mn |
| Dec 31, 2020 | 1.63 Mn |
| Sep 30, 2020 | 6.84 Mn |
| Jun 30, 2020 | 3.46 Mn |
Kamada Gains from Equity Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-equity-investments&ticker=KMDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-equity-investments", "ticker": "KMDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-equity-investments&ticker=KMDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();